Prasenjit Manna

Dr. Prasenjit Manna


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2019 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
NTNeelam Thakur
Neelam Thakur
PMPrasenjit Manna
Prasenjit Manna
JDJoydeep Das
Joydeep Das
Nanoceria has recently received much attention, because of its widespread biomedical applications, including antibacterial, antioxidant and anticancer activity, drug/gene delivery systems, anti-diabetic property, and tissue engineering. Nanoceria exhibits excellent antibacterial activity against both Gram-positive and Gram-negative bacteria via the generation of reactive oxygen species (ROS). In healthy cells, it acts as an antioxidant by scavenging ROS (at physiological pH). Thus, it protects them, while in cancer cells (under low pH environment) it acts as pro-oxidant by generating ROS and kills them. Nanoceria has also been effectively used as a carrier for targeted drug and gene delivery in vitro and in vivo models. Besides, nanoceria can also act as an antidiabetic agent and confer protection towards diabetes-associated organ pathophysiology via decreasing the ROS level in diabetic subjects. Nanoceria also possesses excellent potential in the field of tissue engineering. In this review, firstly, we have discussed the different methods used for the synthesis of nanoceria as these are very important to control the size, shape and Ce3+/Ce4+ ratio of the particles upon which the physical, chemical, and biological properties depend. Secondly, we have extensively reviewed the different biomedical applications of nanoceria with probable mechanisms based on the literature reports. The outcome of this review will improve the understanding about the different synthetic procedures and biomedical applications of nanoceria, which should, in turn, lead to the design of novel clinical interventions associated with various health disorders.

1 August 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SDSaikat Dewanjee
Saikat Dewanjee
SDSonjit Das
Sonjit Das
ADAnup Kumar Das
Anup Kumar Das
NBNiloy Bhattacharjee
Niloy Bhattacharjee
ADAnjum Dihingia
Anjum Dihingia
PMPrasenjit Manna
Prasenjit Manna

1 November 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NBNiloy Bhattacharjee
Niloy Bhattacharjee
SBSujata Barma
Sujata Barma
NKNandita Konwar
Nandita Konwar
SDSaikat Dewanjee
Saikat Dewanjee
PMPrasenjit Manna
Prasenjit Manna

1 November 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SSSanjib Sarkar
Sanjib Sarkar
DDDibyendu Das
Dibyendu Das
PDPrachurjya Dutta
Prachurjya Dutta
JKJatin Kalita
Jatin Kalita
SWSawlang Borsingh Wann
Sawlang Borsingh Wann
PMPrasenjit Manna
Prasenjit Manna

6 September 2018 in BioFactors
Verified
Journal Article
Closed access
PDF file
DDDibyendu Das
Dibyendu Das
SSSanjib Sarkar
Sanjib Sarkar
JBJijnasa Bordoloi
Jijnasa Bordoloi
SWSawlang Borsingh Wann
Sawlang Borsingh Wann
JKJatin Kalita
Jatin Kalita
PMPrasenjit Manna
Prasenjit Manna